Study of Topical Calcitriol in Children With Psoriasis

Treatment of Psoriasis With Parathyroid Hormone

NCT00007306 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Adrenal Suppression and Pharmacokinetics of Topicort® Spray, 0.25% in Pediatric Patients With Plaque Psoriasis

NCT02340169 ·Status: COMPLETED ·Phase: PHASE4

Investigation of Antipsoriatic Effects of UVB-induced Synthesis of 1alpha, 25-Dihydroxyvitamin D3 (1alpha, 25(OH)2D3, Calcitriol)in Keratinocytes of Psoriatic Skin, Using Cytochrom-P(CYP)Inhibitor Ketokonazol

NCT00678756 ·Status: UNKNOWN ·Phase: PHASE2

Study of Dose-Effect of COL-121 Ointment in Patients With Plaque-Type Psoriasis

NCT00625326 ·Status: COMPLETED ·Phase: PHASE2

Nicotinamide in the Treatment of Psoriasis

NCT01763424 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

NCT00763555 ·Status: COMPLETED ·Phase: PHASE2

Effect of Vitamin D Supplementation on Metabolic Parameters of Patients With Psoriasis

NCT02271971 ·Status: COMPLETED ·Phase: NA

Topical Scalp Psoriasis Study Evaluating Topicort Topical Spray

NCT02985736 ·Status: COMPLETED ·Phase: PHASE4

CT 327 in the Treatment of Psoriasis Vulgaris

NCT00995969 ·Status: COMPLETED ·Phase: PHASE2

The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases

NCT00005660 ·Status: COMPLETED

Characterization of Lipoprotein Composition and Function in Pediatric Psoriasis Before and After Treatment

NCT03791216 ·Status: COMPLETED

Evaluate Safety and Tolerability of Calcipotriene Foam 0.005% in Pediatric Subjects With Mild/Moderate Plaque Psoriasis

NCT01582932 ·Status: COMPLETED ·Phase: PHASE1

Phase 2, Open-label, Study of KD025 in Subjects With Psoriasis Vulgaris Who Failed First-line Therapy

NCT02317627 ·Status: COMPLETED ·Phase: PHASE2

A 12-Day Randomized, Blinded, Vehicle and Active Comparator-Controlled Study to Determine the Efficacy and Safety of Six Concentrations of Topical E6201 Gel in Subjects With Psoriasis Vulgaris

NCT01268527 ·Status: COMPLETED ·Phase: PHASE2

Thalidomide in the Treatment of Chronic Plaque Psoriasis.

NCT01891019 ·Status: COMPLETED ·Phase: PHASE2

Climatotherapy Versus Topical Combination of Corticosteroids and Salicylic Acid in Treatment of Psoriasis

NCT03156062 ·Status: UNKNOWN ·Phase: NA

Narrowband UVB Phototherapy in the Treatment of Psoriasis Vulgaris

NCT00844363 ·Status: TERMINATED ·Phase: NA

Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of CD 2027 Spray in Adults With Plaque-type Psoriasis

NCT00763503 ·Status: COMPLETED ·Phase: PHASE2

The Effectiveness of Lower Cyclosporine Doses for Psoriasis

NCT00377325 ·Status: WITHDRAWN ·Phase: PHASE2

Etanercept With Tacrolimus for Psoriasis

NCT00134394 ·Status: COMPLETED ·Phase: PHASE2

Moderate to Severe Plaque Psoriasis With Scalp Involvement

NCT00791765 ·Status: COMPLETED ·Phase: PHASE4

A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis

NCT07102888 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Trial of CF101 to Treat Patients With Psoriasis

NCT01265667 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Efficacy and Safety Study of Apremilast (CC-10004) in Pediatric Subjects From 6 Through 17 Years of Age With Moderate to Severe Plaque Psoriasis

NCT03701763 ·Status: COMPLETED ·Phase: PHASE3

An Investigational Study of Cyclosporine on Experimental Medication BMS-986165 in Healthy Male Participants

NCT03419910 ·Status: COMPLETED ·Phase: PHASE1